Stock DNA
Pharmaceuticals & Biotechnology
CNY 1,576 Million (Small Cap)
43.00
NA
1.30%
-0.03
1.63%
0.71
Revenue and Profits:
Net Sales:
165 Million
(Quarterly Results - Jun 2025)
Net Profit:
8 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
14.7%
0%
14.7%
6 Months
9.7%
0%
9.7%
1 Year
19.55%
0%
19.55%
2 Years
-2.48%
0%
-2.48%
3 Years
-2.16%
0%
-2.16%
4 Years
14.41%
0%
14.41%
5 Years
27.46%
0%
27.46%
Jilin Jian Yisheng Pharmaceutical Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-6.57%
EBIT Growth (5y)
-20.56%
EBIT to Interest (avg)
5.93
Debt to EBITDA (avg)
0.38
Net Debt to Equity (avg)
-0.04
Sales to Capital Employed (avg)
0.28
Tax Ratio
15.50%
Dividend Payout Ratio
63.53%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
3.70%
ROE (avg)
3.80%
Valuation key factors
Factor
Value
P/E Ratio
43
Industry P/E
Price to Book Value
0.71
EV to EBIT
55.28
EV to EBITDA
20.11
EV to Capital Employed
0.70
EV to Sales
2.37
PEG Ratio
NA
Dividend Yield
1.30%
ROCE (Latest)
1.26%
ROE (Latest)
1.63%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bullish
Mildly Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ
Jun'25
Mar'25
Change(%)
Net Sales
164.70
155.10
6.19%
Operating Profit (PBDIT) excl Other Income
14.10
24.30
-41.98%
Interest
3.30
3.20
3.13%
Exceptional Items
-6.20
1.00
-720.00%
Consolidate Net Profit
7.80
12.00
-35.00%
Operating Profit Margin (Excl OI)
16.10%
82.80%
-6.67%
USD in Million.
Net Sales
QoQ Growth in quarter ended Jun 2025 is 6.19% vs -2.51% in Mar 2025
Consolidated Net Profit
QoQ Growth in quarter ended Jun 2025 is -35.00% vs -30.64% in Mar 2025
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
653.50
836.20
-21.85%
Operating Profit (PBDIT) excl Other Income
82.60
137.30
-39.84%
Interest
14.00
13.80
1.45%
Exceptional Items
6.40
2.90
120.69%
Consolidate Net Profit
50.70
96.10
-47.24%
Operating Profit Margin (Excl OI)
53.50%
103.80%
-5.03%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is -21.85% vs 2.79% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is -47.24% vs 8.83% in Dec 2023
About Jilin Jian Yisheng Pharmaceutical Co., Ltd. 
Jilin Jian Yisheng Pharmaceutical Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






